EM Systems Co (4820) AI Stock Analysis

• Market Cap: ¥47.97B
• Dividend Yield: 5.28%
• Average Volume (3M): 50.37K
• Price to Earnings (P/E): 20.1
• Beta (1Y): 0.55
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: JP
• Employees: 827
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.72
• Shares Outstanding: 70,514,800
• 10 Day Avg. Volume: 52,900
• 30 Day Avg. Volume: 50,366
• PEG Ratio: 8.60
• Price to Book (P/B): 2.69
• Price to Sales (P/S): 2.32
• P/FCF Ratio: 51.20
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 28.9
• Revenue Forecast (FY): ¥22.00B

• Rating: 69 Neutral
• Price Target: ¥770.00 ▲(9.53% Upside)
• Action: N/A Date: 02/20/26
• Date: Action: N/A 02/20/26

The score is driven primarily by strong financial quality (especially a conservative balance sheet and solid profitability) and supportive shareholder return via a high dividend yield. These positives are offset by weak technicals (price below key moving averages with negative MACD and oversold momentum) and the key fundamental risk of uneven cash-flow consistency, including a significant 2025 pullback versus 2024.

Positive Factors

Conservative balance sheet

EM Systems' very low leverage and sizable equity base provide durable financial flexibility. A conservative balance sheet supports capex, product investment, and resilience to cyclical pressure, reducing refinancing risk and enabling strategic moves without stressing cash flow over the next several quarters.

Strong profitability and margins

High gross and healthy net margins indicate the business captures pricing power or has efficient cost structures in its healthcare IT niche. Durable margins support cash generation and reinvestment ability, helping sustain returns even if revenue growth moderates in the medium term.

Multi-year revenue expansion in healthcare IT

Consistent multi-year top-line growth, including a large 2025 increase, reflects product adoption in healthcare and pharmacy systems. The company’s exposure to medical information services offers structural demand support, helping sustain revenue momentum and product lifecycle investments over months to years.

Negative Factors

Cash-flow volatility

Operating and free cash flow swung materially between 2024 and 2025, undermining predictability of internal financing. This volatility constrains long-term planning, raises the importance of liquidity buffers, and can limit steady shareholder returns or reinvestment if weak years recur.

Profit compression / uneven profitability

Profit compression in 2025 despite limited revenue decline suggests margin sensitivity to cost or mix shifts. Uneven historical growth increases execution risk: management must stabilize margins and revenue consistency to ensure sustainable earnings and cash generation over the coming quarters.

Rising leverage trend

While absolute leverage remains low, the upward trend in debt and stepped-up total assets raise execution and return expectations. Continued increases could erode the company’s conservative financing advantage and reduce optionality if cash flow remains volatile in the medium term.

EM Systems Co Business Overview & Revenue Model

Company Description

EM Systems Co., Ltd. develops and sells various IT systems for pharmacies, clinics, and care/welfares in Japan. It also develops and sells IT systems for pharmacies, such as medical fee receipt computers and electronic medication record systems; IT systems for clinics, including medical accounting and electronic medical record systems; and office processing systems for care/welfare providers. The company was founded in 1980 and is headquartered in Osaka, Japan.

How the Company Makes Money

EM Systems Co Financial Statement Overview

Summary

Overall fundamentals are solid, supported by strong profitability and multi-year revenue growth. The balance sheet is a major strength with very low leverage, but cash flow is volatile and 2025 showed a material pullback in operating cash flow/free cash flow versus 2024, alongside some profit compression.

Income Statement

Profitability is solid, with healthy gross profit and operating profitability in recent years (2024 gross margin ~55% and net margin ~9.8%). The business also shows a strong multi-year revenue expansion from 2021–2024, and the latest annual report (2025) still indicates strong revenue growth (+23.0%). However, 2025 shows some profit compression versus 2024 (lower gross profit and EBIT despite only a modest revenue decline), and 2020 included a revenue contraction, indicating growth can be uneven.

Balance Sheet

The balance sheet appears very strong and conservatively financed: debt is low relative to equity (debt-to-equity ~0.07 in 2024, near-zero in earlier years) and equity has remained sizable and stable (~¥19–21B) versus total assets (~¥26–32B). Returns on equity are also healthy for the profile (~11.8% in 2024). The main watch item is that debt increased from very low levels in 2021–2022 to higher levels in 2024–2025, and total assets stepped up in 2024, which can raise execution/return expectations.

Cash Flow

Cash generation is mixed. 2024 was very strong with high operating cash flow and free cash flow (free cash flow ~¥5.36B, close to net income), but 2025 shows a notable pullback (operating cash flow ~¥2.01B and free cash flow ~¥1.07B). Earlier years show volatility (2020 was weak, followed by improvement in 2021–2022). Overall, cash flow can be strong, but consistency and year-to-year stability are the key weaknesses.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	19.23B	23.66B	24.84B	16.92B	14.44B	13.37B
Gross Profit	9.96B	11.47B	13.56B	8.28B	7.09B	6.65B
EBITDA	4.63B	4.97B	5.27B	3.77B	3.58B	2.27B
Net Income	2.52B	2.45B	2.42B	1.89B	1.83B	1.28B
Balance Sheet
Total Assets	28.99B	27.51B	31.67B	26.35B	24.81B	23.10B
Cash, Cash Equivalents and Short-Term Investments	10.68B	7.85B	11.88B	8.88B	8.29B	7.98B
Total Debt	985.00M	584.00M	1.44B	109.00M	5.00M	0.00
Total Liabilities	8.50B	7.07B	11.05B	6.85B	5.98B	3.48B
Stockholders Equity	20.46B	20.39B	20.59B	19.48B	18.78B	16.00B
Cash Flow
Free Cash Flow	0.00	1.07B	5.36B	2.02B	1.12B	92.00M
Operating Cash Flow	0.00	2.01B	5.76B	2.47B	1.71B	589.33M
Investing Cash Flow	0.00	-2.22B	194.00M	-577.00M	-544.00M	-196.00M
Financing Cash Flow	0.00	-3.84B	-3.57B	-1.32B	-693.00M	-1.45B

EM Systems Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2413	70 Outperform	¥1.17T	23.50	12.15%	1.01%	33.50%	17.26%
4820	69 Neutral	¥47.97B	20.15	15.71%	5.28%	―	―
3902	63 Neutral	¥65.48B	226.81	―	0.39%	6.17%	-8918.66%
4483	63 Neutral	¥273.19B	39.51	―	0.43%	20.55%	48.62%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
4480	51 Neutral	¥64.95B	64.70	8.79%	―	31.95%	-40.95%
4438	45 Neutral	¥3.02B	-5.60	―	―	16.19%	-4.42%

EM Systems Co Corporate Events

EM Systems Posts Lower Sales but Maintains Solid Financial Base in FY2025

EM Systems Co., Ltd. reported a 4.7% decline in net sales to ¥23.66 billion for the year ended December 2025, with operating profit down 17.6% and ordinary profit down 16.8%, though profit attributable to owners of the parent edged up 1.1% to ¥2.45 billion as earnings per share rose slightly. Despite lower revenue and profit margins, the company strengthened its financial position, with total assets falling, capital adequacy ratio improving to 73.9%, and operating cash flow shrinking while cash and equivalents decreased, signaling a more conservative balance sheet ahead of its planned shareholder meeting and dividend payment in late March 2026.

Net assets were broadly stable at about ¥20.4 billion, and return on equity rose to 12.0%, indicating sustained profitability relative to shareholders’ equity despite softer top-line performance. Cash flows from investing activities turned negative and financing outflows increased, leading to a lower cash balance at year-end, factors that stakeholders will watch closely as the company navigates a period of slower growth and tighter cash generation.

EM Systems Revamps Board and Audit Structure Ahead of March 2026 Meeting

EM Systems announced planned changes to its board of directors and corporate auditors, to take effect following the 43rd Ordinary General Meeting of Shareholders on March 27, 2026. The company named candidates for director roles, including representative and external directors, and outlined the expected transition in its audit and supervisory committee membership.

The company also disclosed that Director and Audit and Supervisory Committee Member Yasuhiro Matsubara will retire from the board but continue to serve as an Audit & Supervisory Board Member at subsidiary UNIKE SOFTWARE RESEARCH. These moves reflect an ongoing refresh of the company’s governance structure while maintaining continuity and oversight within its broader corporate group.

EM Systems Co. Reports FY2025 Results and Sets Outlook for 2026

EM Systems Co. has released its results of operations for the financial year ended December 31, 2025, outlining a performance overview, segment status, and progress under its mid-term management plan. The company also presented an earnings forecast for the 2026 fiscal year and detailed its approach to shareholder returns, signaling ongoing efforts to align financial performance, strategic execution, and capital policy for stakeholders.